Boehringer Ingelheim Spain significantly increased its R&D&I investment to 62.7 million euros, up 36% from the previous year, representing 11.5% of net sales. Their human health...
Ventea, an innovative startup specializing in renewable energy technologies, expands its reach globally with partnerships in the Mediterranean basin, South America, and agreements with Korean and...
Bitpanda Technology Solutions expands its partnership with Raiffeisen Banking Group to 55 additional banks in Lower Austria and Burgenland, Austria. Customers can now invest in over...
Colombian startup Wallib launches a Visa debit card, enabling Bitcoin, USD, and Colombian peso payments worldwide. Users get 2% BTC cashback. CEO Cristian Peñaranda aims to...
A crowdfunding campaign for Campanar fire victims stirs controversy as funds go solely to homeowners, excluding tenants. Initiated by a falla association, the campaign aims to...
The discontinuation of Lemon Skunk and the introduction of Jack Haze by Spectrum Therapeutics are significant events in the medical cannabis market that shed light on...
Zolgensma, Novartis' gene therapy for SMA, remains the world's most expensive medicine, priced between $1.2 million and $2.1 million per dose. Despite its high cost, it's...
FTX unveils a new reorganization plan, offering hope for creditors after its dramatic collapse. Under the plan, billions could flow to creditors, with 98% expected to...
European stock markets tread cautiously amidst mixed signals: positive corporate profits clash with uncertainty over central banks' next moves. ECB member Pierre Wunsch's speech looms for...
The pharmaceutical industry sees a surge in R&D investment, reaching $145.5 billion last year, 4.5% higher than drug launch budgets in 2022. Deloitte's report on pharmaceutical...